Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
What trial data described as typical: Mild redness (less than coin-sized) Slight swelling or firmness Minimal itching or tenderness Resolves completely within 2 days Prevention approaches described in trial protocols and community sources: Rotating injection sites (abdomen, thighs, upper arms) Allowing peptide to reach room temperature before injection Proper injection technique Avoiding the same spot for 2+ weeks Documented signs that warranted medical evaluation: Expanding redness beyond injection site Warmth or heat at injection site Pus or discharge Red streaking from injection site Fever or systemic symptoms Heart Rate Increase Frequency: 6% of trial participants Onset: 1-6 hours post-injection Duration: Can persist 12-24 hours Severity: Usually small increase (2-6 bpm average) Heart rate increases are common with GLP-1 agonists and result from the peptide's effects on cardiac conduction
But fullness, appetite, and metabolic signals can still feel unpredictable
An intramuscular injection contains vitamin B12 only
PMID: 37110608 Sci Rep Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancer
